ReaPath

Tissue specific/ multi-tissue disease models
Potential to use Autologous cells for Patient-Derived-disease phenotypes, e.g...PDX assays
Potential for personalization, ethnicity, genotype specific interrogation of pathology
3 layers to mimic morphology of disease/ lesions to assess/ customize tissue/ site specific efficacy and ADME
Disease mimicking conditions incorporated into the assay
Genotyping
Identification and and analysis of tissue-specific as well as circulating biomarkers
Provisional Patent filed

Applications include test assays for Cancer, Diabetes and Liver Disease

Inflammation